535
-0.93%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Seikagaku
Its shares trade on Tokyo Stock Exchange under the ticker 4548.T. It has been listed since 23 March 2004. In the fiscal year to 31 March 2026, it reported revenue of ¥36.65bn and net income of ¥1.47bn. At that date it held total assets of ¥86.34bn and shareholders' equity of ¥75.30bn.
Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2004-03-23. The firm operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Mar 2004
- Employees
- 744
- Website
- seikagaku.co.jp ↗
Leadership
Pay as last reported
- Mr. Ken MizutaniPresident, Chief Executive Officer, Representative Director, since 2004
- Mr. Toshiyuki OkadaManaging Executive Officer, Director, since 2015
- Mr. Yosuke FunakoshiSenior Executive Officer, Chief Director of Research & Development, Director, since 2016
- Mr. Yuji ShimojimaSenior Executive Officer
- Mr. Masayuki ItoExecutive Officer, Chief Director of Production
- Mr. Kazushi TakedaExecutive Officer
- Mr. Ryoji TomoakiyoExecutive Officer, Chief Director of Business Promotion, Director of Overseas Business Promotion
- Ms. Mio MinakiIndependent Director
- Mr. Yasuyuki SugiuraIndependent Director
- Mr. Daisuke SugiyamaDirector of Accounting, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong Research and Development: Seikagaku Corp has a proven track record of investing in research and development, allowing them to develop innovative and high-quality products.
- Wide Product Portfolio: The company offers a diverse range of products in the fields of pharmaceuticals, medical devices, and biomaterials, providing them with a competitive edge in multiple markets.
- Established Brand: Seikagaku Corp has a well-established brand reputation, recognized for its commitment to quality and reliability, which helps to build trust among customers and stakeholders.
Weaknesses
- Limited Global Presence: While Seikagaku Corp has a strong presence in its domestic market, their international operations are relatively limited, which restricts their opportunities for global growth.
- Dependence on a Few Key Products: The company relies heavily on a small number of key products for a significant portion of its revenue, making it vulnerable to market fluctuations and potential disruptions in the supply chain.
- Limited Financial Resources: Seikagaku Corp may face challenges in financing future expansion plans due to limited financial resources, impacting their ability to invest in new ventures or acquisitions.
Opportunities
- Emerging Markets: Expanding into emerging markets, such as Asia and Latin America, presents significant growth opportunities for Seikagaku Corp, as these regions have a rising demand for healthcare and pharmaceutical products.
- Technological Advancements: Harnessing technological advancements, such as biotechnology and nanotechnology, can enable Seikagaku Corp to develop breakthrough products and enhance their competitive advantage in the market.
- Partnerships and Collaborations: Forming strategic partnerships and collaborations with other companies or research institutions can help Seikagaku Corp to access new expertise, expand their product offerings, and enter new markets more efficiently.
Threats
- Intense Competition: Seikagaku Corp operates in a highly competitive industry, making it vulnerable to price wars, new entrants, and changing customer preferences, which could impact market share and profitability.
- Regulatory Challenges: Compliance with regulatory standards and requirements in different countries can pose challenges for Seikagaku Corp, leading to delays in product approvals, increased costs, or limitations on market access.
- Economic Uncertainty: Fluctuations in global economic conditions, such as recessions or currency fluctuations, can impact consumer demand for healthcare products and affect Seikagaku Corp's financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.